Clinical Trials in San Francisco

Showing 2541-2560 of 11,161 trials

Optimizing Provider Training in Eating Disorders (OPTED)

NCT05389657

This is a randomized controlled trial for mental health clinicians comparing two methods of training in family-based treatment (FBT) for restrictive eating disorders.

Anorexia NervosaAtypical Anorexia Nervosa

University of California, San Francisco85 participantsStarted Jul 2022

San Francisco, California, United States

COMPLETEDNA< 1 mile

Hemodynamic-GUIDEd Management of Heart Failure

NCT03387813

The GUIDE-HF IDE clinical trial is intended to demonstrate the effectiveness of the CardioMEMS™ HF System in an expanded patient population including heart failure (HF) patients outside of the present indication, but at risk for future HF events or mortality.

Heart FailureHeart Failure, SystolicHeart Failure, Diastolic+7 more

Abbott Medical Devices2,358 participantsStarted Mar 2018

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +126 more locations

Optimizing Provider Training in Eating Disorders (OPTED)

Hemodynamic-GUIDEd Management of Heart Failure

Find Trials by Condition in San Francisco

LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis

A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

The Symptomatic Cerebral Cavernous Malformation Trial of REC-994

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

SLC13A5 Deficiency Natural History Study - United States Only

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis